Case Study: Lyell Immunopharma achieves GMP-ready, data-driven cell therapy production with Körber’s Werum PAS-X MES as a Service

Lyell leverages Werum PAS-X MES as a Service for clinical phase production to support GMP and data-driven operation

Lyell Immunopharma, a US-based clinical-stage cell therapy biotech, needed a digital foundation to scale autologous T cell cancer therapy production while maintaining GMP compliance and preparing for future commercial growth. To avoid paper-based processes and support data integrity from the start, Lyell turned to Körber AG and its Werum PAS-X MES as a Service offering for clinical phase manufacturing.

Körber AG implemented a cloud-based, fully managed PAS-X MES solution on AWS using a ready-to-run cell and gene therapy package, minimizing customization and speeding deployment. The result was a more digitized manufacturing operation with fewer manual steps and human errors, improved efficiency and compliance, and a path toward faster releases through better data visibility and future system integrations.

Lyell Immunopharma

Joe Maguire

Head of GMP Automation and Data